Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/2009
07/23/2009WO2007080622A8 Luminescent stem cells and uses thereof
07/23/2009WO2005056752A9 Methods and compositions for delivering polynucleotides
07/23/2009US20090188010 Insect Chymotrypsin and Inhibitors Thereof
07/23/2009US20090188005 Methods for genetic control of plant pest infestation and compositions thereof
07/23/2009US20090188004 Protein Kinase Stress-Related Proteins and Methods of Use in Plants
07/23/2009US20090188000 Gene family (lbfl313) associated with pancreatic cancer
07/23/2009US20090187996 Ion Channel
07/23/2009US20090187006 originated from Pleurotus cornucopiae having an antifungal activity against at least rice blast (Magnaporthe grisea);
07/23/2009US20090187004 Chimeric protein comprising contains human immunodeficiency virus protein transduction domain ; protein transduction domain (PTD) having HIV Tat PTD activity, polypeptidyl fragment that contains a J-domain and a target protein
07/23/2009US20090186921 Azacyclic compounds
07/23/2009US20090186846 Methods to reprogram splice site selection in pre-messenger RNAs
07/23/2009US20090186822 Thrombopoietic Compounds
07/23/2009US20090186820 Streptococcus pyogenes polypeptides and corresponding dna fragments
07/23/2009US20090186817 Peptide-peptidase inhibitor conjugates and methods of using same
07/23/2009US20090186816 Polypeptide targeting to mitochondria
07/23/2009US20090186815 Identification of jak/stat pathway modulating genes by genome wide rnai screening
07/23/2009US20090186813 Chronic treatment regimen using glucagon-like insulinotropic peptides
07/23/2009US20090186812 Apo-2 ligand
07/23/2009US20090186811 Y2 Selective Receptor Agonists for Therapeutic Interventions
07/23/2009US20090186806 Truncated Activin Type II Receptor and Methods of Use
07/23/2009US20090186422 Peptide for use in the treatment of immunological defects and allergies; capable of inhibiting protein-protein interaction between calcineurin and NFAT
07/23/2009US20090186402 Detection instrument with the use of polynucleotides mapped on barley chromosome
07/23/2009US20090186391 Method for Production of Erythro-or threo-2-Amino-3-Hydroxypropionic Acid Ester, Novel Carbonyl Reductase, Gene for the Reductase, Vector, Transformant, and Method for Production of Optically Active Alcohol Using Those
07/23/2009US20090186390 Method for the Production of Modified Steroid Degrading Microorganisms and their Use
07/23/2009US20090186379 ERK ligands and polynucleotides encoding ERK ligands
07/23/2009US20090186376 sVEGFR-2 AND ITS ROLE IN LYMPHANGIOGENESIS MODULATION
07/23/2009US20090186369 Polysaccharide-protein binding model and nano-fibril formation of a starch binding domain
07/23/2009US20090186358 Pathway Analysis of Cell Culture Phenotypes and Uses Thereof
07/23/2009US20090186355 Method for determination and quantification of radiation or genotoxin exposure
07/23/2009US20090186338 Oligonucleotides originating from sequences coding for the surface component of ptlv envelope proteins and their uses
07/23/2009US20090186337 N protein of a virus of the paramyxoviridae family-protein of interest fusion proteins
07/23/2009US20090186075 Composition
07/23/2009US20090186048 Tuberculosis vaccines comprising antigens expressed during the latent infection phase
07/23/2009US20090186046 Hepatitis C Virus Non Structural Fusion Protein
07/23/2009US20090186045 Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants
07/23/2009US20090186044 Type iv collagen-like immunoreactive peptide
07/23/2009US20090186043 Method and compositions for preventing and treating streptococcus pneumoniae infection
07/23/2009US20090186037 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith
07/23/2009US20090186036 Anti-Alpha V Beta 6 Antibodies
07/23/2009US20090186029 Anticholesterol agents; generating an antibody which binds specifically to a C-terminal fragment of a vertebrate hedgehog polypeptide, comprising immunizing a mammalian subject with the C-terminal fragment
07/23/2009US20090186023 Antibodies directed against hepatitis c virus e1e2 complex, compositions of hcv particles, and pharmaceutical compositions
07/23/2009US20090186018 Compositions and methods for the treatment of rheumatoid arthritis
07/23/2009US20090186008 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
07/23/2009US20090186002 rAAV-delivered alpha-1-antitrypsin compositions and method for the treatment and prevention of diabetes
07/23/2009US20090185998 New activated poly(ethylene glycols) and related polymers and their applications
07/23/2009US20090185997 Methods of suppressing microglial activation and systemic inflammatory responses
07/23/2009US20090185979 Integrin Heterodimer and an Alpha Subunit Thereof
07/23/2009DE202006020682U1 Mittel zur Diagnose von rheumatischen Erkrankungen Means for the diagnosis of rheumatic diseases
07/23/2009DE19521753B4 Monomere Insulinanalogonformulierungen Monomeric insulin analog formulations
07/23/2009DE112007002172T5 A/D-Wandler, A/D-Umwandlungsverfahren, A/D-Umwandlungsprogramm und Steuervorrichtung A / D converter, A / D converting method, A / D conversion program and control device
07/23/2009CA2712475A1 Vaccine comprising a ribosomal protein extract (rpe) and optionally a th1-promoting adjuvant
07/23/2009CA2712309A1 Composition and method for diagnosis or detection of renal cancer
07/23/2009CA2712079A1 Compositions and methods of detecting post-stop peptides
07/23/2009CA2711972A1 Anti-bacterial compositions
07/23/2009CA2711930A1 A truncated form of the hiv p17 protein
07/23/2009CA2711375A1 Purification of not-glycosylated polypeptides
07/22/2009EP2081028A1 Use of a polypeptide to detect, prevent or treat a pathological state associated with a degenerative, neurological, autoimmune illness
07/22/2009EP2081026A1 Marker for inflammatory conditions
07/22/2009EP2080812A1 Compositions and methods of detecting post-stop peptides
07/22/2009EP2080809A1 Production of modified glycoproteins having multiple antennary structures
07/22/2009EP2080805A1 Plant expression vectors
07/22/2009EP2080804A1 Modified cytokines for use in cancer therapy
07/22/2009EP2080803A1 Plastid transformation vectors for expressing proinsulin fused to the cholera toxin B-subunit in plants
07/22/2009EP2080802A2 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
07/22/2009EP2080772A2 Recombinant polypeptides and methods for detecting and/or quantifying autoantibodies against TSH receptor
07/22/2009EP2080771A2 New interferon beta-like molecules
07/22/2009EP2080770A1 Proteinaceous binding molecules comprising purification tags
07/22/2009EP2080769A2 Process for the production of fine chemicals
07/22/2009EP2080768A1 Method for studying virus particle release
07/22/2009EP2080766A1 B7-related nucleic acids and polypeptides useful for immunomodulation
07/22/2009EP2080525A1 Remodeling and Glycoconjugation of Peptides
07/22/2009EP2080521A1 Gastrin compositions and formulations, and methods of use and preparation
07/22/2009EP2080520A1 Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiogenesis
07/22/2009EP2080519A1 Peptides having binding affinity to an antibody which recognizes an epitope on an alpha1 loop 2 or beta 2 loop 1 of an adrenoreceptor
07/22/2009EP2080432A1 Sugar and lipid metabolism regulators in plants III
07/22/2009EP2079840A1 Immunotox n fusions comprising an antibody fragment and a plant toxin linked by protease cleavable linkers
07/22/2009EP2079761A2 Prevention of aggregation of immunoglobulin light or heavy chains
07/22/2009EP2079758A1 Method for the purification of dnak
07/22/2009EP2079757A2 Process for selectively localizing active ingredients on and in mitochondria and corresponding active ingredients
07/22/2009EP2079755A1 Process for generation of protein and uses thereof
07/22/2009EP2079526A1 Compositions and uses thereof in the treatment of wounds
07/22/2009EP2006377A9 Novel tumor antigen peptides
07/22/2009EP1846448B1 Diagnosis of allergic complaints, atopic diseases and/or auto-immune diseases by the identification of antibodies against cd28 in human serum
07/22/2009EP1836316A4 Methods for expression and purification of recombinant human growth hormone
07/22/2009EP1804822B1 Hcv vaccines for chronic hcv patients
07/22/2009EP1794287B1 Use of il-17- for maturation of oocytes
07/22/2009EP1697404B1 Cc-chemokine binding tick proteins
07/22/2009EP1685402B1 Hairless protein-interacting partner complexes and methods thereof for the beautification and/or improvement of mammalian skin
07/22/2009EP1664109B1 Purification of glucagon-like peptides
07/22/2009EP1646653B1 Method of obtaining biologically active collagen from skins of the salmonidae fish
07/22/2009EP1629082A4 Glucose transport-related genes and uses thereof
07/22/2009EP1597274B1 Hsp60 from arthrobacter
07/22/2009EP1514838B1 Process for producing nanoparticles
07/22/2009EP1511767B1 A purified polypeptide, isolated nucleic acids encoding said polypeptide, vectors and use thereof
07/22/2009EP1471937B1 A continuous cell line for the production of vaccines
07/22/2009EP1443053B1 Analgesic antitumor peptide from scorpion and method of producing it
07/22/2009EP1395293B1 Lentiviral vectors encoding clotting factors for gene therapy
07/22/2009EP1357938B1 Hyperblebbing bacterial strains and use thereof for production of vaccines
07/22/2009EP1297110B1 Attenuated bovine respiratory syncytial virus
07/22/2009EP1292697B1 Method for preparing a physiologically active il-18 polypeptide